IVERIC bio Statistics
Share Statistics
IVERIC bio has 137.98M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 137.98M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 642 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -14.75 and the forward
PE ratio is null.
IVERIC bio's PEG ratio is
-0.5.
| PE Ratio | -14.75 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 4.85 |
| P/FCF Ratio | -15.75 |
| PEG Ratio | -0.5 |
Financial Ratio HistoryEnterprise Valuation
IVERIC bio has an Enterprise Value (EV) of 2.21B.
| EV / Sales | 0 |
| EV / EBITDA | -11.51 |
| EV / EBIT | -13.51 |
| EV / FCF | -13.45 |
Financial Position
The company has a current ratio of 18.63,
with a Debt / Equity ratio of 0.18.
| Current Ratio | 18.63 |
| Quick Ratio | 18.63 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | -0.51 |
| Debt / FCF | -0.59 |
| Interest Coverage | -83.88 |
Financial Efficiency
Return on Equity is -32.86% and Return on Invested Capital is -28.49%.
| Return on Equity | -32.86% |
| Return on Assets | -26.36% |
| Return on Invested Capital | -28.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,078,190.18 |
| Employee Count | 163 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -9.47M |
| Effective Tax Rate | 5.11% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 1.1, so IVERIC bio's
price volatility has been higher than the market average.
| Beta | 1.1 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 38.02 |
| 200-Day Moving Average | 26.09 |
| Relative Strength Index (RSI) | 69.05 |
| Average Volume (20 Days) | 4,945,949 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -189.91M |
| Net Income | -175.75M |
| EBITDA | -192.28M |
| EBIT | -182.95M |
| Earnings Per Share (EPS) | -1.45 |
Full Income StatementBalance Sheet
The company has 476.3M in cash and 97.77M in
debt, giving a net cash position of 378.54M.
| Cash & Cash Equivalents | 476.3M |
| Total Debt | 97.77M |
| Net Cash | 378.54M |
| Retained Earnings | -864.81M |
| Total Assets | 613.41M |
| Working Capital | 572.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -163.77M
and capital expenditures -736K, giving a free cash flow of -164.51M.
| Operating Cash Flow | -163.77M |
| Capital Expenditures | -736K |
| Free Cash Flow | -164.51M |
| FCF Per Share | -1.36 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
